Literature DB >> 24077327

Nanoparticle accumulation and transcytosis in brain endothelial cell layers.

Dong Ye1, Michelle Nic Raghnaill, Mattia Bramini, Eugene Mahon, Christoffer Åberg, Anna Salvati, Kenneth A Dawson.   

Abstract

The blood-brain barrier (BBB) is a selective barrier, which controls and limits access to the central nervous system (CNS). The selectivity of the BBB relies on specialized characteristics of the endothelial cells that line the microvasculature, including the expression of intercellular tight junctions, which limit paracellular permeability. Several reports suggest that nanoparticles have a unique capacity to cross the BBB. However, direct evidence of nanoparticle transcytosis is difficult to obtain, and we found that typical transport studies present several limitations when applied to nanoparticles. In order to investigate the capacity of nanoparticles to access and transport across the BBB, several different nanomaterials, including silica, titania and albumin- or transferrin-conjugated gold nanoparticles of different sizes, were exposed to a human in vitro BBB model of endothelial hCMEC/D3 cells. Extensive transmission electron microscopy imaging was applied in order to describe nanoparticle endocytosis and typical intracellular localisation, as well as to look for evidence of eventual transcytosis. Our results show that all of the nanoparticles were internalised, to different extents, by the BBB model and accumulated along the endo-lysosomal pathway. Rare events suggestive of nanoparticle transcytosis were also observed for several of the tested materials.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24077327     DOI: 10.1039/c3nr02905k

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  30 in total

Review 1.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

2.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

3.  Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor.

Authors:  Hsiangkuo Yuan; Christy M Wilson; Jun Xia; Sarah L Doyle; Shuqin Li; Andrew M Fales; Yang Liu; Ema Ozaki; Kelly Mulfaul; Gabi Hanna; Gregory M Palmer; Lihong V Wang; Gerald A Grant; Tuan Vo-Dinh
Journal:  Nanoscale       Date:  2014-03-11       Impact factor: 7.790

Review 4.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

5.  Ultrathin Silicon Membranes for in Situ Optical Analysis of Nanoparticle Translocation across a Human Blood-Brain Barrier Model.

Authors:  Diána Hudecz; Tejas Khire; Hung Li Chung; Laurent Adumeau; Dale Glavin; Emma Luke; Morten S Nielsen; Kenneth A Dawson; James L McGrath; Yan Yan
Journal:  ACS Nano       Date:  2020-01-14       Impact factor: 15.881

6.  Inhalation of Silver Silicate Nanoparticles Leads to Transient and Differential Microglial Activation in the Rodent Olfactory Bulb.

Authors:  Huong Huynh; Priya Upadhyay; Cora H Lopez; Malia K Miyashiro; Laura S Van Winkle; Sara M Thomasy; Kent E Pinkerton
Journal:  Toxicol Pathol       Date:  2022-06-29       Impact factor: 1.930

7.  Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes.

Authors:  Jacob McCright; Colin Skeen; Jenny Yarmovsky; Katharina Maisel
Journal:  Acta Biomater       Date:  2022-04-02       Impact factor: 10.633

8.  Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors.

Authors:  Hyesun Hyun; Joonyoung Park; Kiela Willis; Ji Eun Park; L Tiffany Lyle; Wooin Lee; Yoon Yeo
Journal:  Biomaterials       Date:  2018-07-18       Impact factor: 12.479

9.  Delivery luteolin with folacin-modified nanoparticle for glioma therapy.

Authors:  Cong Wu; Qian Xu; Xinyue Chen; Jiagang Liu
Journal:  Int J Nanomedicine       Date:  2019-09-16

Review 10.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.